NCT02057874 2018-07-11
3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
Clinical Trials
11 trialsNCT00373152 2017-12-05
MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT00033397 2017-07-13
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
Alliance for Clinical Trials in Oncology
Completed
NCT00537056 2017-06-14
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Phase NA Completed
NCT01996527 2017-04-17
3T MRI Biomarkers of Glioma Treatment Response
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02278510 2017-03-31
Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02967380 2017-03-27
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
University of Southern California
Phase NA Terminated
NCT01047059 2016-05-20
MIMEB
University of Cologne
Phase 2 Completed
NCT01956409 2016-02-04
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
National Taiwan University Hospital
Phase 4 Unknown
NCT00060008 2014-04-04
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia
Phase NA Terminated
NCT00005790 2012-06-11
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Northwestern University
Phase NA Withdrawn